Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect.

Targeted cancer therapies are currently a strong focus in biomedical research. The most common approach is to use nanocarrier-based targeting to specifically deliver conventional anticancer drugs to enhance their therapeutic efficacy, increase bioavailability, and decrease the side-effects on normal cells. A step further towards higher specificity and efficacy would be to employ specific novel drugs along with specific nanocarrier-based targeting. Our recent studies have demonstrated that a plant-derived diterpenoid compound, anisomelic acid (AA), induces apoptosis in cervical cancer cells. In this work, we describe the development of a folic acid (FA)-targeted AA delivery system using chitosan-coated rod-shaped mesoporous silica particles (Chitosan-NR-MSP). The cellular internalization and uptake enhancement of the FA-Chitosan-NR-MSP towards cancerous folate receptor (FR)-positive (SiHa and HeLa) and/or normal FR-negative (HEK 293) cells were assessed, which indicated that the intracellular uptake of FA-conjugated Chitosan-NR-MSP was more target-specific. Furthermore, the induction of apoptosis by AA-loaded chitosan-coated rod-shaped particles on SiHa cells was studied. By employing caspase-3 activation and PARP cleavage as measure of apoptosis, the FA-particle mediated AA treatment was clearly more effective, significantly enhancing apoptosis in comparison to non-targeted Chitosan-NR-MSP or free AA in SiHa cells, suggesting that the FA-Chitosan-NR-MSPs can be potentially utilized as a drug delivery system for cervical cancer treatment.

[1]  G. Chirico,et al.  Gold nanostars for superficial diseases: a promising tool for localized hyperthermia? , 2014, Nanomedicine.

[2]  Bin Wu,et al.  Evaluation of the biocompatibility of a chitosan scaffold in mice. , 2002, Journal of biomedical materials research.

[3]  Ali Khademhosseini,et al.  Biocompatibility of engineered nanoparticles for drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[4]  J. Masters.  HeLa cells 50 years on: the good, the bad and the ugly , 2002, Nature Reviews Cancer.

[5]  Paula T Hammond,et al.  The effects of polymeric nanostructure shape on drug delivery. , 2011, Advanced drug delivery reviews.

[6]  V. Torchilin,et al.  Micellar Nanocarriers: Pharmaceutical Perspectives , 2006, Pharmaceutical Research.

[7]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[8]  Cecilia Sahlgren,et al.  Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. , 2011, Current drug targets.

[9]  Richard A Gemeinhart,et al.  Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  Y. Ikada,et al.  Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media. , 1995, Bioconjugate chemistry.

[11]  Sakari Hietanen,et al.  Novel action modality of the diterpenoid anisomelic acid causes depletion of E6 and E7 viral oncoproteins in HPV-transformed cervical carcinoma cells. , 2014, Biochemical pharmacology.

[12]  S. Kosaraju,et al.  Bioadhesive chitosan nanoparticles: Preparation and characterization , 2010 .

[13]  Zongxi Li,et al.  Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. , 2010, Small.

[14]  Marlus Chorilli,et al.  Nanotechnology-based drug delivery systems and herbal medicines: a review , 2013, International journal of nanomedicine.

[15]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[16]  D. Laurents,et al.  Carbodiimide EDC induces cross-links that stabilize RNase A C-dimer against dissociation: EDC adducts can affect protein net charge, conformation, and activity. , 2009, Bioconjugate chemistry.

[17]  Victor S-Y Lin,et al.  Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. , 2005, Angewandte Chemie.

[18]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[19]  Dong Li,et al.  Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations , 2012, Anti-cancer drugs.

[20]  Ming-Jium Shieh,et al.  Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. , 2010, Bioconjugate chemistry.

[21]  Jun Jie Wang,et al.  Recent advances of chitosan nanoparticles as drug carriers , 2011, International journal of nanomedicine.

[22]  G. Lu,et al.  A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles , 2012 .

[23]  K. Lee,et al.  Plant-derived natural product research aimed at new drug discovery , 2008, Journal of Natural Medicines.

[24]  D. Mcclements,et al.  Influence of tripolyphosphate cross-linking on the physical stability and lipase digestibility of chitosan-coated lipid droplets. , 2010, Journal of agricultural and food chemistry.

[25]  S. Fulda.  Modulation of apoptosis by natural products for cancer therapy. , 2010, Planta medica.

[26]  J. M. Córdoba,et al.  Rapid synthesis of SBA-15 rods with variable lengths, widths, and tunable large pores. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[27]  V. Labhasetwar,et al.  Characterization of nanoparticle uptake by endothelial cells. , 2002, International journal of pharmaceutics.

[28]  V. Sinha,et al.  Biodegradable microspheres for protein delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Xiaoxi Hu,et al.  Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release. , 2014, Chemistry, an Asian journal.

[30]  M. Odén,et al.  Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization , 2012, Nanoscale Research Letters.

[31]  A. Alshatwi,et al.  Analysis of the Cytotoxic Potential of Anisomelic Acid Isolated from Anisomeles malabarica , 2013, Scientia pharmaceutica.

[32]  Aliasger K. Salem,et al.  Multifunctional Nanorods for Biomedical Applications , 2007, Pharmaceutical Research.

[33]  A. Alshatwi,et al.  Antiproliferative property of n-hexane and chloroform extracts of Anisomeles malabarica (L). R. Br. in HPV16-positive human cervical cancer cells , 2012, Journal of pharmacology & pharmacotherapeutics.

[34]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[35]  G. Shah,et al.  Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[36]  Xia Li,et al.  Identification of pathways involved in paclitaxel activity in cervical cancer. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[37]  Arun Kumar,et al.  Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy , 2012, International journal of nanomedicine.